Introduction
Radiolabeled substances have been widely used in laboratory procedures to track or trace macromolecules in intact cells, and their clinical use for the diagnosis of various diseases, including cancer, is increasing rapidly. Accordingly, there is a great deal of interest in elucidating the biological consequences of autoirradiation caused by these substances. This knowledge is important not only for risk assessment because of exposure in the workplace, clinic, and environment, but also for evaluating the validity of the results obtained with many assay systems that utilize radiolabeled cells.
The mechanisms underlying the cellular responses to genotoxic stress are best understood for DNA-damaging agents such as ionizing radiation and 254 nm ultraviolet (UV) light. It is well established that exposure of normal human fibroblasts (NHFs) to ionizing radiation and other DNA strand-breaking agents activates the ATM protein kinase, which in turn mediates the stabilization of the p53 protein, its translocation to the nucleus, and activation of p53-mediated events (Giaccia and Kastan, 1998; Rotman and Shiloh, 1999) . A key player in the ATM-dependent DNA damage-surveillance network is p21
WAF1
, a p53-regulated gene whose encoded protein (p21) mediates the G 1 /S cell cycle checkpoint by inhibiting the activity of cyclin/cyclin-dependent kinase complexes (Rotman and Shiloh, 1999) , protects against apoptosis by inhibiting caspase 3 (Suzuki et al., 2000) , and switches on the cellular senescence program by regulating the expression of senescence-associated genes (Chang et al., 2000) . Exposure of normal cells to UV light also results in p53 protein stabilization, although this response appears to be mediated by an ATMindependent mechanism (Enns et al., 2000) . UV light produces two types of bulky DNA lesions, cyclobutane pyrimidine dimer (CPD) and (6-4) photoproduct, both of which are repaired by the nucleotide excision repair pathway (Galloway et al., 1994) . We (Mirzayans et al., 1996; Barley et al., 1998) and others (Aboussekhra et al., 1995; Smith et al., 1995) have provided evidence that p53 and p53-regulated gene products have auxiliary roles in the nucleotide excision repair of UV-induced DNA lesions.
Metabolic labeling of human cells with low-energy beta-emitting radioisotopes such as [ (Yeargin and Haas, 1995; Hu et al., 2001) . Notably, Dover et al. (1994) observed a marked increase in p53 mRNA levels following pulse labeling of NHFs with [ 3 H]dThd, suggesting that p53 protein accumulation may result in part from increased expression of the p53 gene. This finding is in contrast to the observations with cells exposed to external beam ionizing radiation, where the accumulation of p53 is shown to reflect solely the post-translational stabilization and activation of the pre-existing protein molecules and not its increased synthesis (Giaccia and Kastan, 1998) .
The purpose of the present study was to determine the cellular and molecular effects of the beta-emitting radioisotopes 
Results

Effect of radiolabeling on cell growth and clonogenic survival
NHFs (strain GM38) and tumor cell lines with differing p53 status were assayed for inhibition of cell growth following treatment with [ 3 H]dThd, both at low specific activity (5 Ci/mmol) and high specific activity (82 Ci/ mmol), and [ 3 H]Urd (27 Ci/mmol). To this end, cultures of each cell line were exposed to various activities of a radionucleoside for 24 h, incubated in fresh medium for 4-6 days, and the cell number in treated and nontreated (control) cultures was determined. The purpose of using different post-treatment incubation times for different cell lines was to allow cells in control cultures to undergo approximately four population doublings. The [ 3 H] nucleosides induced growth arrest in all cell lines examined ( Figure 1a) . The average IC 50 values (i.e., radionucleoside activities resulting in 50% growth inhibition) for cell lines expressing WT p53 (i.e., GM38, A549, A172, and HCT116) and cell lines lacking WT p53 (i.e., DLD-1, BT20, SKOV-3, and HCT116 p53À/À ) amounted to B0.07 mCi/ml (range, 0.04-0.10 mCi/ml) and B0.27 mCi/ml (range, 0.18-0.32 mCi/ml) for We also determined the responses of the fibroblast strains and tumor cell lines to [ 14 C]dThd (stock specific activity, 55 mCi/mmol). Unlike the tritiated nucleosides that are used in a wide range of activities in DNA repair and nucleic acid synthesis assays, [ 14 C]dThd is usually used at extremely low activities (e.g., 0.005 mCi/ml in studies reported by us) to uniformly label the genomic DNA. Thus, the highest activity of [ 14 C]dThd used in the present studies was 0.4 mCi/ml for the growth/survival assays and 0.1 mCi/ml for other assays described below. As shown in Figure 1a , a 24-h incubation of NHFs and tumor cell lines with these activities of [ 14 C]dThd did not produce any effect on their proliferation. Likewise, such treatment did not influence the colony-forming ability of NHFs and ATM-deficient fibroblasts (data not shown).
Effect of radiolabeling on p53 and p21 protein levels Exposure of NHFs to ionizing radiation results in stabilization of endogenous p53 protein, induces rapid translocation of p53 to the nucleus and enhances its transcriptional activity, leading to increased expression of a number of proteins (e.g., p21) encoded by p53 target genes. These radiation-induced responses are dependent on the ATM protein kinase. We therefore determined the influence of radiolabeled nucleosides on p53 and p21 protein levels in NHFs and in ATM-deficient (Figure 3 ). To rule out the possibility that the failure of these ATM-deficient cells to upregulate p53/p21 in response to radiolabeling may be associated with defects in the p53 gene itself, we performed direct sequencing of exons 2-11 of the p53 gene in AT2BE and AT5BI and demonstrated the presence of WT sequences in these strains (for details, visit www.cancerboard.ab.ca/davidmurray). Furthermore, as expected from previous studies , these ATM-deficient strains exhibited marked p53 protein accumulation following exposure to UV light ( Figure 3 ). Collectively, these results indicate that all [
3 H]-triggered p53/p21 upregulation seen in NHFs is dependent on ATM.
Expression of p53 and p21
WAF1 mRNA after radiolabeling
Two sets of experiments were carried out to determine the influence of radiolabeled nucleosides on the expression of the p53 and p21 WAF1 genes. In the first set of experiments, NHFs and several tumor cell lines were incubated with [ 3 H]dThd (10 mCi/ml; stock specific activity, 87 Ci/mmol) for 24 h and assayed for p53 and p21 WAF1 transcript levels by Northern blotting. In the second set, NHFs and A172 cells were treated with different radiolabeled nucleosides for 24 h and then assessed by Northern blotting. Typical blots are shown in Figure Effect of radiolabeling on nucleotide excision repair as determined by a sensitive immunofluorescence assay
Metabolic labeling of human cells with [
3 H]dThd is commonly used in DNA repair assays (Mirzayans et al., 1996; Ford et al., 1998; Hwang et al., 1999; Bowman et al., 2000; Smith et al., 2000) . Since we demonstrated here that [ 3 H] labeling induces nuclear accumulation of p53, and because p53 is known to influence nucleotide excision repair (Wang et al., 1995) , we determined the impact of radiolabeling on the repair of UV-induced CPDs. For the experiments presented in Figures 5a and b, NHFs were exposed to graded fluences of UV between 1 and 6 J/m 2 and fixed immediately using methanol. The cells were then treated with HCl to denature genomic DNA and subjected to immunostaining using an antibody specific for CPDs. Under these conditions, significant levels of CPDs were detected after the lowest UV fluence administered (1 J/m 2 ; Figure 5a ) and the amounts of CPDs increased linearly as a function of UV fluence over the range between 1 and 4 J/m 2 ( Figure 5b ). To determine the effect (if any) of radiolabeling on CPD repair, NHFs were incubated for 24 h in the presence or absence of [ 3 H]dThd at either 1 or 10 mCi/ml. The cells were then exposed to UV light at 4 J/m 2 , incubated for various times (0, 6, 12, and 24 h) and assayed for CPDs by immunostaining. The results from multiple independent experiments are averaged in Figure 5 . The levels of immunostaining observed immediately after UV exposure were comparable in labeled and nonlabeled cultures (Figure 5b ), indicating the induction of similar levels of CPDs in the two cultures. In the absence of radiolabeling, CPDs underwent repair at a relatively slow rate in NHFs, such that by 24 h postirradiation B35% of the lesions remained in the genome (Figure 5c ), that is, these cells exhibited B65% repair during the 24-h period. The extent of repair measured in [ 3 H]-labeled cultures at 6, 12, and 24 h after UV exposure was greater than that in nonlabeled cultures (Figure 5c ). Cultures labeled with [ 3 H]dThd (either 1 or 10 mCi/ml) exhibited B65% repair during 12 h of post-UV incubation, which is approximately two times the extent of repair seen in nonlabeled cultures during the same period. Post-UV incubation times required to remove 50% of CPDs by [ 3 H]-labeled and nonlabeled cultures amounted to B6 and B12 h, respectively.
Control
0.05 µCi/ml 1 µCi/ml 10 µCi/ml p53 levels If so, then p53-deficient cells should have a reduced repair rate and radiolabeling should not accelerate repair in the absence of WT p53 function. To investigate a possible role for p53 in accelerated repair, we carried out repair studies with p53-deficient NHFs (strain GM38 expressing HPV-16 E6) and human colon carcinoma HCT116 cells in which both p53 alleles are inactivated (Bunz et al., 1998) . A 24-h incubation of both p53-deficient cultures with [ 3 H]dThd did not influence the rate of CPD repair after 4 J/m 2 UV exposure (Figures 5d and e) . Of particular note, the rate of repair in [ 3 H]-labeled and nonlabeled p53-deficient cells was slower than the rate in nonlabeled, p53-proficient NHFs.
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We also carried out experiments with the parental HCT116 cell line that expresses WT p53. As shown in Figure 5e , the rate of repair of CPDs in nonlabeled HCT116 cells was rapid, and comparable to the rate displayed by [ 3 H]-labeled NHFs. Unlike NHFs, however, [
3 H] labeling of the parental HCT116 cells did not result in accelerated repair.
In all of these experiments, the genomic DNA of the cells was denatured with HCl prior to immunostaining. When the denaturing step was eliminated, immunostaining by the use of the CPD-specific antibody could not be detected in cultures that had been exposed to UV (p6 J/ m 2 ) and either assayed immediately or after incubation for 3, 6, and 24 h (371C) to allow repair (data not shown). Thus, the immunostaining detected in denatured cells ( Figure 5 ) corresponded to antibody-reacting lesions (CPDs) present in genomic DNA and not to other UV-associated alterations such as excision fragments, that is, single-stranded DNA fragments containing CPDs that are generated in the course of nucleotide excision repair (Galloway et al., 1994) .
Discussion
Radioactive tracer substances are increasingly being used in modern medicine. Determining the biological consequences of exposure to these substances is crucial not only for risk assessment, but also for evaluating the validity of results obtained with many assay systems that utilize radiolabeling. In this inquiry, we focused on the biological effects of beta-emitting radiolabeled nucleosides that are commonly used in studying DNA repair and nucleic acid metabolism in mammalian cells exposed to DNA-damaging agents. Owing to the tremendous technical benefits of using radioisotopes for tracing specific macromolecules, our aim here was not only to investigate the possible effects evoked by commonly used radiolabeling procedures, but also to determine which radiolabeling conditions (if any) can be employed without adversely affecting or perturbing cell function.
The DNA-damage surveillance circuitry activated by ionizing radiation involves ATM-dependent post-translational modification of the p53 protein, resulting in accumulation of p53 in the nucleus and induction of p53-mediated responses (Giaccia and Kastan, 1998 ], which emits a short-range beta particle (maximum range, B5 mm in water) such that only energy deposition from nucleic-acid-incorporated isotope is likely to elicit deleterious biological effects.
As mentioned earlier, p53 plays an auxiliary role in the nucleotide mode of excision repair. In our previous work, the absence of WT p53 in human fibroblasts was shown to confer a DNA repair deficiency similar to that seen in cells belonging to complementation group E of the UV hypersensitivity disorder xeroderma pigmentosum (XP) . Subsequently, it was reported that p53 regulates the DDB-2 gene, which is mutated in a subset of XPE patients (Hwang et al., 1999; Wakasugi et al., 2002) . Cells lacking WT p53 or the DDB-2 gene product are characterized by a reduced initial rate of nucleotide excision repair (Galloway et al., 1994; Barley et al., 1998 ] labeling may cause alteration of chromatin structure by a p53-dependent or -independent mechanism, thereby rendering DNA lesions more accessible to repair complexes. Indeed, labeling of human cells with low-energy beta-emitting radioisotopes is known to induce DNA strand breaks (Hu et al., 2001) , which may facilitate chromatin unfolding.
In contrast to NHFs, [ 3 H] labeling of the p53 WT colon carcinoma cell line HCT116, its p53À/À derivative, and E6-expressing NHFs did not lead to acceleration of the repair of UV-induced CPDs (Figures 5d and  e) . The rate of repair in p53-deficient cells was, however, slower than in nonlabeled p53 WT cells, providing further support for the involvement of p53 in nucleotide excision repair. The failure of [ 3 H] labeling to accelerate repair in p53-deficient cells argues against p53-independent alterations, such as mechanical unfolding of the chromatin structure by DNA strand breaks per se, as being responsible for [ 3 H]-triggered accelerated repair seen in NHFs. The rate of repair in parental HCT116 cells that express WT p53 was rapid and similar to the rate displayed by [ 3 H]-labeled NHFs (Figure 5e ). We interpret this response to indicate that the rate of repair of CPDs in nonlabeled HCT116 cells is optimal, such that induction of p53 by radiolabeling does not further increase the repair rate. Interestingly, abrogation of p53 had a greater impact on CPD repair in HCT116 cells than in GM38 fibroblasts (Figure 5d and e) , which raises the possibility that p53 may play a more pronounced role in nucleotide excision repair in these colon carcinoma cells than in NHFs.
Recently, several studies have suggested that caution should be exercised when interpreting results obtained with assay systems involving radiolabeled cultures to determine the cellular responses to genotoxic stress, as the results may be misleading because of induction of p53 by radiolabeling itself (e.g., Bond et al., 1999; Hu & Heikka, 2000; Hu et al., 2001) . In view of the results presented here, we conclude that previous results determining the effects of DNA-damaging agents on end points such as de novo DNA synthesis (a measure of S-phase checkpoint; Mirzayans et al., 1995) , S-phase index (a measure of G 1 /S checkpoint; Enns et al., 1999), and recovery of RNA synthesis (a measure of repair of transcription-blocking DNA lesions; Barley et al., 1998; Mirzayans et al., 1999) are not influenced by radiolabeling because these assays involve incubation of the cells with extremely low activities of [ 14 C]dThd (e.g., 0.005 mCi/ml) for 24 h followed by pulse labeling with p10 mCi/ml of [ 3 H]dThd or [ 3 H]Urd for no more than 1 h. Such radiolabeling conditions do not induce p53 (this study), and thus there is no reason to consider the results obtained by these assays compromised. Likewise, the previous results for quantifying repair DNA synthesis by in situ autoradiography are unlikely to be influenced by artefacts such as p53-dependent modulation of repair because this assay involves pulse labeling the cells with high activities of [ 3 H]dThd for 1 h or less which, in the light of our current findings (Figure 2) , should have little or no impact on repair.
On the other hand, our results suggest that the measurement of repair rates by techniques that involve prelabeling of genomic DNA with [ 3 H]dThd for 5 h or longer times can be overestimated by as much as twofold in certain cell types (e.g., noncancerous human fibroblasts). Although in such techniques the cells are prelabeled with very low activities of [ 3 H]dThd, typically between 0.1 and 1 mCi/ml (Mirzayans et al., 1996; Ford et al., 1998; Hwang et al., 1999; Bowman et al., 2000; Smith et al., 2000) , we have shown here that prelabeling of NHFs with 0.05 mCi/ml [ 3 H]dThd (stock specific activity, 5 Ci/mmol) results in nuclear accumulation of p53 and growth arrest (Figures 1 and 2) . Our studies further demonstrate that, unlike labeling with [ In the present study, we have demonstrated for the first time the feasibility of employing a conventional immunofluorescence approach to visualize the induction and repair of specific DNA lesions -in this case, UVinduced CPDs. Several lines of recent evidence highlight the need for sensitive and reliable assays for monitoring DNA damage and repair following exposure to very low, noncytotoxic doses of DNA-damaging agents. The immunofluorescence assay for DNA damage employed here should be particularly useful in this regard, not only in view of our observations showing that this assay can be used to detect DNA damage after exposure to extremely low fluences of UV light without the need for radiolabeling, but also owing to its applicability to virtually all types of DNA damage for which monoclonal antibodies are available.
Although this study focused on determining the biological consequences of radionucleosides routinely used in laboratory procedures, our findings may have clinical relevance. In the current study, the extent of cell growth following [
3 H] labeling of tumor cell lines was found to be dependent on their p53 status. As shown in Figure 1a, 
Materials and methods
Cells and culture conditions
The normal human fibroblast strain GM38 was purchased from the Institute for Medical Research (Camden, NJ, USA). The AT fibroblast strains AT4BI and AT5BI were a generous gift of Dr AMR Taylor (University of Birmingham, Birmingham, UK) and Dr AR Lehmann (University of Sussex, Brighton, UK), respectively. The AT fibroblast strain AT2BE (originally designated CRL1343) and the human tumor cell lines expressing WT p53 (A549, lung carcinoma; A172, malignant glioma) or mutant p53 (DLD-1, colon carcinoma; SKOV-3, ovarian carcinoma; BT20, breast carcinoma) were purchased from American Type Culture Collection (Rockville, MD, USA). The colon carcinoma cell line HCT116 and its p53À/À derivative (clone 379.2; Bunz et al., 1998) were a generous gift of Dr B Vogelstein (John Hopkins University, Baltimore, MD, USA). The HPV-16 E6-expressing NHFs were generated in the laboratory by transfecting GM38 fibroblasts with the pCMV-Bam-Neo-E6 plasmid (Gaitonde et al., 2001) , which was kindly provided by Dr JD Martinez (University of Arizona, Tucson, AZ, USA). The transfection and establishment of G418-resistant (E6 expressing) cultures were performed as described by Gaitonde et al. (2001) . Absence of WT p53 in transfected cells was confirmed by immunostaining for p53 and p21 protein levels before and after treatment with [ 3 H]dThd (data not shown). All cell types were routinely cultured as monolayers in dThd-free Ham's F12 medium supplemented with 10% (v/v) fetal bovine serum, 1 mm l-glutamine, 100 IU/ml penicillin G, and 100 mg/ml streptomycin sulfate in a 371C chamber incubator providing a humidified atmosphere of 5% CO 2 in air. All cultures were free of Mycoplasma contamination.
Radiolabeled nucleosides
The radiolabeled nucleosides [methyl- 3 H]dThd (stock specific activity, 5 or 87 Ci/mmol), [methyl-14 C]dThd (specific activity, 55 mCi/mmol), and [ 3 H]Urd (specific activity, 27 Ci/mmol) were purchased from Amersham Pharmacia Biotech (Baie d'Urfe¨, PQ, Canada). The tritiated nucleosides were used within 2 months of purchase.
Irradiation
Cells were rinsed in phosphate-buffered saline (PBS) and exposed to 254 nm UV light or 60 Co g radiation as described (Mirzayans et al., 1992) .
Growth inhibition assay
Monolayer cultures in late logarithmic growth phase were harvested by trypsinization, plated out at 5 Â 10 4 cells either in 60-mm (tumor cell lines) or 100-mm (NHFs) tissue culture dishes, and incubated overnight. Cells were treated for 24 h with different activities of a radiolabeled nucleoside in culture medium at a volume of 3 ml (60-mm dishes) or 8 ml (100-mm dishes). After removal of the radioactive medium and gentle rinsing of the cells in PBS, the cells were incubated in fresh medium for 4-6 days and then harvested by trypsinization and counted using a Coulter counter (Coulter, Hialeah, FL, USA). Growth inhibition curves were constructed by plotting the extent of cell growth as a function of activity of the radiolabeled nucleoside administered. IC 50 values were determined as the radionucleoside activities required to induce 50% inhibition of cell growth. The reason for using different posttreatment incubation times for different cell lines was to provide sufficient time for cells in control dishes (incubated without radionucleosides) to undergo approximately four population doublings.
Clonogenic survival assay
Fibroblast cultures in late logarithmic growth phase were plated out in 60-mm dishes (10 5 cells/dish) and incubated overnight. Cells were treated with different activities of a radiolabeled nucleoside for 24 h, whereupon they were harvested by trypsinization and plated out at various densities (200-20 000) in 100-mm dishes. After incubation for 2-3 weeks (with weekly medium renewals), the cells were stained with crystal violet and the number of macroscopic colonies (i.e., aggregates of 450 cells) scored. Survival curves were constructed by plotting colony-forming ability (expressed as a percentage of the control cultures) on a logarithmic scale as a function of the isotope activity in the culture medium on a linear scale.
Northern blotting
Cells were seeded in 100-mm dishes at 1 Â 10 6 /dish and incubated overnight. The cells were then treated with different activities of a radiolabeled nucleoside (or sham-treated) for 24 h and harvested by the use of trypsin. Total RNA was isolated using TRIzol reagent (GIBCO-BRL, Burlington, ON, Canada) according to the manufacturer's directions. RNA was resolved on 1.5% agarose-formaldehyde gels (20 mg RNA per lane) and transferred to Hybond-N þ membranes (Amersham). After baking at 801C for 1 h, each membrane was hybridized with [ 32 P]dCTP-labeled probes generated using the Oligolabeling Kit (Amersham), and exposed to Kodak XAR-5 film at À701C with an intensifying screen. The intensity of the resulting bands corresponding to p21 WAF1 , p53, or b-actin transcripts was quantified using a digitized image analyzer (BC Cancer Research Centre, Cancer Imaging, Vancouver, BC, Canada). The probes were synthesized by PCR using total human cDNA as the substrate and the following primers: p21
WAF1
, 5
0 -CCAAGAGGAAGCCC TAATCC-3 0 (forward), and 5 0 -CCCCTTCAAAGTGCCAT CTG-3 0 (reverse); p53, 5 0 -TTTGGGTCATTGAACCCTTG-3 0 (forward) and 5 0 -GGTTTCAAGGCCAGATGTAC-3 0 (reverse); b-actin, 5 0 -CCTCGCCTTTGCCGATCC-3 0 (forward) and 5 0 -GGATCTTCATGAGGTAGTCAGTC-3 0 (reverse).
Western blotting
Fibroblast cultures were plated out in 100-mm dishes at 0.5 Â 10 6 / dish and incubated for 48 h, and then treated with radiolabeled nucleosides as indicated. The cells were detached, lysed, and subjected to Western blotting using a p53-specific monoclonal antibody (1801) or a p21-specific monoclonal antibody (both from Santa Cruz Biotechnology, Santa Cruz, CA, USA) as described . To confirm equal protein loading, each membrane was stained with 0.05% copper phthalo-cyanine 3,4 0 ,4 00 ,4 000 -tetrasulfonic acid tetrasodium salt (CPTS) after completion of Western blotting (Bickar and Reid, 1992) .
Immunofluorescence assay for p53
Exponentially growing NHFs were washed with PBS, trypsinized, transferred into 35-mm dishes with glass coverslips, and incubated overnight at 371C. Cells on coverslips were washed with PBS, fixed in methanol for 20 min at À201C, incubated with 0.5% Triton X-100 for 5 min, and washed again with PBS. Cells were incubated with PBS containing 5% nonfat dry Carnation milk for 30 min, stained with anti-p53 antibody (1801) and then with AlexaFluor 488 goat anti-mouse IgG (Molecular Probes, Eugene, OR, USA). Each antibody was used at 1 : 100 dilution in PBS containing 5% nonfat dry milk. Coverslips were incubated on 30 ml drops of each antibody on parafilm for 1 h at room temperature in a humidified chamber. After each antibody treatment, cells were washed with PBSTween 20 (3 min) and PBS (three times, 3 min each). Cells were examined with an Axiophot microscope (Carl Zeiss, Jena, Germany) using a band filter of 450-490 nm. Images were captured and processed using the Metamorph program and Adobe Photoshop, respectively. Immunofluorescence signals were quantified using a digitized image analyzer (BC Cancer Research Cancer Centre).
Immunofluorescence assay for CPD
The protocol for CPD immunofluorescence was similar to p53 immunostaining except that the DNA of cells was denatured with HCl prior to antibody treatment. To this end, after fixing in methanol and Triton X-100, the cells were incubated at room temperature with 2 m HCl for 30 min, washed two times (5 min each) with borate buffer (pH 8.5), and washed three times with PBS. After blocking in milk (5%), the cells were incubated with a CPD-specific monoclonal antibody (Kamiya Biomedical, Seattle, WA, USA) diluted at 1 : 100 in PBS containing 5% milk.
